AI assistant
Sending…
EIDP, Inc. — Director's Dealing 2005
Feb 4, 2005
35588_dirs_2005-02-04_7200d951-a6eb-4675-b506-f15985435de3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DUPONT E I DE NEMOURS & CO (DD)
CIK: 0000030554
Period of Report: 2005-02-02
Reporting Person: JOHNSON W DONALD (Group Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-02-02 | Common Stock | A | 1963 | $48.05 | Acquired | 11118 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-02-02 | Stock Options (right to buy) NQOs | $48.05 | A | 35800 | Acquired | 2011-02-01 | Common Stock (35800) | Direct |
| 2005-02-02 | Restricted DuPont Common Stock Units | $ | A | 4700 | Acquired | Common Stock (4700) | Direct | |
| 2005-02-02 | Restricted DuPont Common Stock Units | $ | A | 4700 | Acquired | Common Stock (4700) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1970 | Indirect |
| Common Stock | 5011.7067 | Indirect |
Footnotes
F1: Options become exercisable in three equal annual installments beginning on the first anniversary of the grant; option shares may be used to satisfy withholding taxes.
F2: Units convert one-for-one to DuPont common stock.
F3: Restricted stock units become payable in DuPont common stock in three equal annual installments beginning on the first anniversary of the grant.
F4: Restricted stock units to be settled in DuPont common stock three years after grant if specific corporate goals are achieved.
More from EIDP, Inc.
Annual Report
2026
Feb 12
Interim / Quarterly Report
2025
Nov 5
Interim / Quarterly Report
2025
Aug 7
Capital/Financing Update
2025
May 14
Capital/Financing Update
2025
May 13
Capital/Financing Update
2025
May 12
Capital/Financing Update
2025
May 12
Regulatory Filings
2025
May 8
Interim / Quarterly Report
2025
May 8
Annual Report
2025
Feb 14